Spotlight on Day 2 Speakers: Where Innovation Meets Regulation

Dr. Christian Groendahl

CEO & Founder, SNIPR – A CRISPR Company

A biotech innovator with over 30 years of experience, Dr. Groendahl is a co‑inventor of foundational CRISPR patents and a driving force behind CRISPR‑based microbiome therapies.

Talk:
Developing CRISPR‑Armed Phages (CAPs) for Treating Multi‑Drug Resistant Infections

Dr. Radu Botgros

Senior Scientific Officer, European Medicines Agency (EMA)

An infectious diseases specialist with extensive expertise in EU regulatory pathways, Dr. Botgros focuses on anti‑infectives, vaccines, and antimicrobial resistance (AMR).

Talk:
Regulatory Expectations for Approval of Phage Therapy Medicinal Products in the European Union

Dr. Alexander Sulakvelidze

President & CEO, Intralytix, Inc.

A global leader in phage technology, Dr. Sulakvelidze has advanced innovations from discovery to clinical and commercial application, including FDA‑cleared products and ongoing clinical trials.

Talk:
Advancing Phage Therapeutics: Intralytix’s Integrated Discovery‑to‑Clinic Platform

Together, these speakers represent the entire translational pathway—from breakthrough science and regulatory frameworks to real‑world clinical and commercial impact.

‍